Scarlett, a retired thoroughbred racehorse and descendant of Secretariat, has become like family for Jenna and her parents, Kim and Matt.

Clinical data from Indaptus’ ongoing Phase 1 trial evaluating Decoy20 in advanced solid tumors.

Russell Bradley Named President & General Manager of CNSide Dr. Marc Hedrick, Rick Hawkins, and Russell Bradley Join CNSide Board of Directors Dr. Jonathan Stein Appointed CNSide Medical Director AUST ...

Dr. Marc Hedrick, Rick Hawkins, and Russell Bradley Join CNSide Board of Directors. Dr. Jonathan Stein Appointed CNSid ...

Discover how immune checkpoint inhibitors represent an exciting avenue for managing field cancerisation and reducing the ...

Use of immune checkpoint inhibitor (ICI) therapy for cancer was associated with a significant reduction in actinic keratoses ...

The Lung Cancer Research Foundation (LCRF) is pleased to announce its partnership with Israel Cancer Research Fund (ICRF) on a project led by Joel Yisraeli, PhD, and his lab in the Department of ...

Pancreatic cancer is fueled by connections to the nervous system. This is reported by scientists from the German Cancer ...

University of Queensland researchers have discovered immunotherapy, when used to treat people with advanced cancers, also ...

近日，上海交通大学医学院附属仁济医院（简称仁济医院）核医学科团队受邀在《Nature Reviews Urology》杂志发表题为“肾癌分子影像：未来已来”（英文题目：Molecular imaging of renal cell ...

Catumaxomab, a first-in-class therapeutic, is specifically designed to treat malignant ascites in adults with certain types of cancer (epithelial cellular adhesion molecule (EpCAM)-positive carcinomas ...

A new pilot cohort study linked immune checkpoint inhibitors with a reduction in actinic keratoses in patients undergoing ...